Lasa Supergenerics Board Meeting on Aug 14 to Review Q1 2026 Results

Lasa Supergenerics Ltd has announced that its Board of Directors will convene on August 14, 2026. The primary agenda items include the consideration and approval of the unaudited financial results for the quarter ended June 30, 2026. Additionally, the board will discuss any other matters with the Chairperson's permission. In line with SEBI regulations, the trading window will remain closed until 48 hours after the declaration of these financial results. The company has also made this information available on its website and the BSE and NSE websites.